a public good project by the
Synthesis
Company
of California

© 2026

James C. Yang | doi.page

0 works0 citations0 h-index

James C. Yang

Texas Tech University(US)National Taiwan University Hospital(TW)

Publications by Year

Research Areas

CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Virus-based gene therapy research, Immune Cell Function and Interaction

Most-Cited Works

→ Cancer immunotherapy: moving beyond current vaccines(2004)2,953 cited
→ Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2(2010)2,493 cited
→ Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer(2014)1,692 cited
→ Adoptive cell transfer: a clinical path to effective cancer immunotherapy(2008)1,646 cited
→ Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor(2014)1,600 cited
→ Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1(2011)1,589 cited

→ B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells(2011)1,437 cited

→ Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen(2009)1,391 cited

→ Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction(1990)1,312 cited

→ A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer(2006)1,232 cited